FDA finds little handwashing, dirty equipment at McDonald's supplier linked to E. coli outbreak
More than a hundred E. coli cases were linked to contaminated onions produced by Taylor Farms used in McDonald's burgers.
FDA finds little handwashing, dirty equipment at McDonald's supplier linked to outbreak
More than a hundred E. coli cases were linked to contaminated onions produced by Taylor Farms used in McDonald's burgers.
FDA issues draft guidance to improve accuracy of pulse oximeters for people with darker skin tones
Years of research have showed that pulse oximeters yield less accurate readings for people with darker skin tones, and now ...
FDA sets limits on lead in some baby foods
But consumer advocates say the Food and Drug Administration's new guidance on lead limit in baby food doesn't go far enough.
Which Foods Are Actually 'Healthy'? The FDA Will Now Tell You
The government agency is tightening its standards for "healthy" claims. And for the first time in 30 years, its labeling rules will be updated to reflect new nutrition standards.
Report: FDA lags on food safety inspections due to COVID-19 backlog
Facing personnel shortages and pandemic disruptions, the U.S. Food and Drug Administration has failed to meet requirements ...
Cure Today50m
A Breakdown of Trial Data that Led to the Subcutaneous Opdivo FDA Approval
Dr. Eric K. Singhi discusses the significance of the FDA approval of subcutaneous Opdivo for patients with solid tumors.
STAT22h
Patrizia Cavazzoni, head of FDA’s drug center, to leave the agency
Patrizia Cavazzoni, leader of the FDA's Center for Drug Evaluation and Research, is leaving the agency on Jan. 18.
Drug to treat rare pediatric disease accepted for FDA review
A subsidiary of a Miami-based company is inching closer to FDA approval for a drug that treats a rare pediatric disease.
Healio21h
FDA grants priority review to nipocalimab for myasthenia gravis
The FDA has granted priority review to a Biologics License Application for nipocalimab to treat individuals with generalized ...
STAT23h
In debate over obesity medications, FDA shifts toward importance of drugs in subtle ways
The changes reflect “a cultural shift” around obesity medications, said Diana Zuckerman, president of the nonprofit National ...
BioPharma Dive22h
Patrizia Cavazzoni, key FDA official, to leave agency
The director of the FDA's main drug review office will exit on Jan. 18, according to an email sent to staff. Her departure is ...